{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:35:27Z","timestamp":1793079327149,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00428-025-04333-w","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T08:56:14Z","timestamp":1763369774000},"page":"1027-1032","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Plasmacytoid dendritic cell clusters are associated with poor prognosis in chronic myelomonocytic leukemia"],"prefix":"10.1007","volume":"489","author":[{"given":"Deepika","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp W.","family":"Raess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahg","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parnaz","family":"Daneshpajouhnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamiaa A.","family":"Fathalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hasserjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel G.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9513-245X","authenticated-orcid":false,"given":"Mina L.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"4333_CR1","doi-asserted-by":"publisher","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia 36(7):1703\u20131719. https:\/\/doi.org\/10.1038\/s41375-022-01613-1","DOI":"10.1038\/s41375-022-01613-1"},{"key":"4333_CR2","doi-asserted-by":"publisher","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR et al (2022) International Consensus Classification of myeloid neoplasms and acute leukemia: integrating morphological, clinical and genomic data. Blood 140(11):1200\u20131228.\u00a0https:\/\/doi.org\/10.1182\/blood.2022015850","DOI":"10.1182\/blood.2022015850"},{"issue":"3","key":"4333_CR3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1182\/blood.v99.3.840","volume":"99","author":"F Onida","year":"2002","unstructured":"Onida F, Kantarjian HM, Smith TL, Ball G, Keating MJ et al (2002) Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood 99(3):840\u2013849. https:\/\/doi.org\/10.1182\/blood.v99.3.840","journal-title":"Blood"},{"issue":"10","key":"4333_CR4","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1182\/blood-2016-05-714030","volume":"128","author":"C Elena","year":"2016","unstructured":"Elena C, Gall\u00ec A, Such E, Meggendorfer M, Germing U et al (2016) Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia. Blood 128(10):1408\u20131417. https:\/\/doi.org\/10.1182\/blood-2016-05-714030","journal-title":"Blood"},{"issue":"5","key":"4333_CR5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/00000478-200405000-00004","volume":"28","author":"W Vermi","year":"2004","unstructured":"Vermi W, Facchetti F, Rosati S, Vergoni F, Rossi E et al (2004) Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes\/interferon-producing cells associated with myeloid disorders. Am J Surg Pathol 28(5):585\u2013595. https:\/\/doi.org\/10.1097\/00000478-200405000-00004","journal-title":"Am J Surg Pathol"},{"key":"4333_CR6","doi-asserted-by":"publisher","unstructured":"Orazi A, Chiu R, O'Malley DP, Czader M, Allen SL et al (2006) Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology. Mod Pathol 19(12):1536\u20131545. https:\/\/doi.org\/10.1038\/modpathol.3800707","DOI":"10.1038\/modpathol.3800707"},{"issue":"10","key":"4333_CR7","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1038\/s41375-019-0447-3","volume":"33","author":"N Lucas","year":"2019","unstructured":"Lucas N, Duchmann M, Rameau P, No\u00ebl F, Michea P et al (2019) Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia. Leukemia 33(10):2466\u20132480. https:\/\/doi.org\/10.1038\/s41375-019-0447-3","journal-title":"Leukemia"},{"issue":"4","key":"4333_CR8","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3324\/haematol.2020.247569","volume":"106","author":"W Wang","year":"2021","unstructured":"Wang W, Khoury JD, Miranda RN, Jorgensen JL, Xu J et al (2021) Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm. Haematologica 106(4):1047\u20131055. https:\/\/doi.org\/10.3324\/haematol.2020.247569","journal-title":"Haematologica"},{"key":"4333_CR9","doi-asserted-by":"publisher","unstructured":"Katz SG, Edappallath S, Xu ML (2021) IRF8 is a reliable monoblast marker for acute monocytic leukemia. Am J Surg Pathol 45(10):1391\u20131398. https:\/\/doi.org\/10.1097\/PAS.0000000000001765","DOI":"10.1097\/PAS.0000000000001765"},{"key":"4333_CR10","doi-asserted-by":"publisher","unstructured":"McQuaid DC, Panse G, Wang WL, Pinkus GS, Katz SG et al(2022) Global assessment of IRF8 as a novel cancer biomarker. Hum Pathol 122:1\u201310. https:\/\/doi.org\/10.1016\/j.humpath.2022.01.004","DOI":"10.1016\/j.humpath.2022.01.004"},{"key":"4333_CR11","doi-asserted-by":"publisher","unstructured":"Tzankov A, Facchetti F, M\u00fchleisen B, Dirnhofer S (2022) IRF8 is a reliable monoblast marker for acute monocytic leukemias but does not discriminate between monoblasts and plasmacytoid dendritic cells. Am J Surg Pathol 46(5):725\u2013727. https:\/\/doi.org\/10.1097\/PAS.0000000000001874","DOI":"10.1097\/PAS.0000000000001874"},{"issue":"7","key":"4333_CR12","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/leu.2013.88","volume":"27","author":"MM Patnaik","year":"2013","unstructured":"Patnaik MM, Padron E, LaBorde RR, Lasho TL, Finke CM et al (2013) Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes. Leukemia 27(7):1504\u20131510. https:\/\/doi.org\/10.1038\/leu.2013.88","journal-title":"Leukemia"},{"key":"4333_CR13","doi-asserted-by":"publisher","unstructured":"Foucar K, Hsi ED, Wang SA, Rogers HJ, Hasserjian RP et al (2020) Concordance among pathologists in classifying blasts plus monocytes. Int J Lab Hematol 42(4):418\u2013422. https:\/\/doi.org\/10.1111\/ijlh.13212","DOI":"10.1111\/ijlh.13212"},{"key":"4333_CR14","doi-asserted-by":"publisher","unstructured":"Sukswai N, Aung PP, Yin CC, Li S, Wang W et al (2019) Dual expression of TCF4 and CD123 is highly sensitive and specific for blastic plasmacytoid dendritic cell neoplasm. Am J Surg Pathol 43(10):1429\u20131437. https:\/\/doi.org\/10.1097\/PAS.0000000000001316","DOI":"10.1097\/PAS.0000000000001316"},{"key":"4333_CR15","doi-asserted-by":"publisher","unstructured":"Saadeh D, Kurban M, Abbas O (2016) Update on the role of plasmacytoid dendritic cells in inflammatory\/autoimmune skin diseases. Exp Dermatol 25(6):415\u2013421. https:\/\/doi.org\/10.1111\/exd.12957","DOI":"10.1111\/exd.12957"},{"key":"4333_CR16","doi-asserted-by":"publisher","unstructured":"Mangaonkar AA, Patnaik MM (2022) Role of the bone marrow immune microenvironment in chronic myelomonocytic leukemia pathogenesis: novel mechanisms and insights into clonal propagation. Leuk Lymphoma 63(8):1792\u20131800. https:\/\/doi.org\/10.1080\/10428194.2022.2056175","DOI":"10.1080\/10428194.2022.2056175"},{"issue":"21","key":"4333_CR17","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1182\/bloodadvances.2020002415","volume":"4","author":"AA Mangaonkar","year":"2020","unstructured":"Mangaonkar AA, Reichard KK, Binder M, Coltro G, Lasho TL et al (2020) Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia. Blood Adv 4(21):5425\u20135430. https:\/\/doi.org\/10.1182\/bloodadvances.2020002415","journal-title":"Blood Adv"},{"key":"4333_CR18","doi-asserted-by":"publisher","unstructured":"Xiao W, Chan A, Waarts MRM, Mishra T, Liu Y et al (2021) Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia. Blood 137(10):1377\u20131391. https:\/\/doi.org\/10.1182\/blood.2020007897","DOI":"10.1182\/blood.2020007897"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04333-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04333-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04333-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:24:53Z","timestamp":1793078693000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04333-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4333"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04333-w","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been approved by the Institutional Review Board of Yale University, Mass General Brigham, OHSU, and the University of Pennsylvania. The study was performed in accordance with the Declaration of Helsinki. Approved institutional IRBs: Yale (#2000023891), OHSU (STUDY00015060), MGB (#2009P001369), and UPenn (#826755).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Permission to reproduce material from other sources","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}